发明公开
- 专利标题: TARGETING VECTOR-PHOSPHOLIPID CONJUGATES
- 专利标题(中): 结合物脱靶中的特定向量和磷脂
-
申请号: EP06840164.5申请日: 2006-12-08
-
公开(公告)号: EP1966388A2公开(公告)日: 2008-09-10
- 发明人: BUSSAT, Philippe , CHERKAOUI, Samir , FAN, Hong (Helen) , LAMY, Bernard , NANJAPPAN, Palaniappa , PILLAI, Radhakrishna, K. , POCHON, Sibylle , SONG, Bo , SWENSON, Rolf, E.
- 申请人: BRACCO International B.V.
- 申请人地址: Strawinskylaan 3051 1077 ZX Amsterdam NL
- 专利权人: BRACCO International B.V.
- 当前专利权人: BRACCO International B.V.
- 当前专利权人地址: Strawinskylaan 3051 1077 ZX Amsterdam NL
- 代理机构: Bassil, Nicholas Charles
- 优先权: US749240P 20051209; US833342P 20060725
- 国际公布: WO2007067979 20070614
- 主分类号: C12P21/04
- IPC分类号: C12P21/04 ; C07K1/00 ; A61K38/16
摘要:
Peptide vectors having high KDR binding affinity and processes for making such vectors are provided. The peptide vectors may be conjugated to phospholipids and included in ultrasound contrast agent compositions. Such ultrasound contrast agents are particularly useful in therapeutic and diagnostic methods, such as in imaging KDR-containing tissue and in the evaluation and treatment of angiogenic processes associated with neoplastic conditions. The present invention also provides processes for the large scale production of highly pure dimeric and monomeric peptide phospholipid conjugates as well as precursor materials used to form the conjugates. The present invention further provides processes for the large scale production of highly pure peptide phospholipid conjugates which contain very low levels of TFA.
公开/授权文献
- EP1966388B1 TARGETING VECTOR-PHOSPHOLIPID CONJUGATES 公开/授权日:2013-08-07
信息查询